Positive Allosteric Modulation of Metabotropic Glutamate 5 (mGlu5) Receptors Reverses N-Methyl-D-Aspartate Antagonist-Induced Alteration of Neuronal Firing in Prefrontal Cortex
- 1 October 2007
- journal article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 62 (7), 739-746
- https://doi.org/10.1016/j.biopsych.2006.12.003
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophreniaMolecular Psychiatry, 2006
- Functional Metabotropic Glutamate Receptors on Nuclei from Brain and Primary Cultured Striatal NeuronsPublished by Elsevier BV ,2005
- Psychiatric medication‐induced obesity: treatment optionsObesity Reviews, 2004
- Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMolecular Psychiatry, 2004
- Hyperprolactinaemia and antipsychotic therapy in schizophreniaCurrent Medical Research and Opinion, 2004
- Activation of Metabotropic Glutamate Receptor mGlu5 on Nuclear Membranes Mediates Intranuclear Ca2+ Changes in Heterologous Cell Types and NeuronsPublished by Elsevier BV ,2003
- (S)‐3,5‐DHPG: A ReviewCNS Drug Reviews, 2002
- Ketamine activates psychosis and alters limbic blood flow in schizophreniaNeuroReport, 1995
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974